3Sanchez-Vargas FM.Gomez-Duarte OG Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen[J].Clin Microbiol Infect,2008,(14):105-115.
4Wilson DN,Harms JM,Nierhaus RH,et al.Species-specific antibiotic ribosome interation:Implications for drug development[J].Biol Chem,2005,386(12):1239-1252.
5Bébéar C.M,Pereyre S.Mechanisms of Drug Resistance in Mycoplasma pneumoniae[J].Current Drug Targets-Infectious Disorders,2005,5(3):263-271.
6Lee KY.Pediatric respiratory infection by Mycoplasma pneumoniae[J].Anti Infect Ther,2008,6(4):509-521.
7胡亚美 江载芳.诸福棠实用儿科学[M]:7版[M].北京:人民卫生出版社,2002.1294.
8Candler PM,Dale RC.Three cases of central nervous system complications associated with Myeoplasma pneumoniae[J].Pediatr Neurol,2004,31(2):133-138.
9Narita M,Tanaka H,Yamada S,et al.Significant role of interhukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection[J].Clin Diagn Lab Immunol,2001,8(5):1028-1030.
10Matsuzono Y,Narita M,Akutsu Y,et al.Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections[J].Acta Paediatr,1995,84(8):879-883.
1Lee KY, Lee HS, Hong JH, etal. Role of prednisolone treat- ment in severe Mycoplasma Pneumoniae in children [J]. Pedi- art Pulmonol, 2006, 41(3): 263-268.
